Aflac (AFL) FY2025 results: revenue $17.2 billion, down 9.3% on the year
Aflac Inc. (AFL) reported revenue of $17.2 billion for fiscal 2025, the year ended 31 December 2025, down 9.3% on the year before. Net income was $3.6 billion, down 33.0%, and diluted earnings per share $6.82. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 1 raised.
- Net earnings fell on lower investment gains: Q4 net earnings were $1.4 billion, or $2.64 per diluted share, against $1.9 billion, or $3.42, a year earlier. Net investment gains were $537 million, against $1.0 billion.
- Adjusted earnings per share edged up: Adjusted earnings were $818 million, down 5.4% from $865 million. Adjusted earnings per diluted share rose 0.6% to $1.57.
- Japan margin dipped to 31.3%: Japan pretax adjusted earnings were ¥109.8 billion, down 3.5% reported and 4.4% currency-neutral. The Japan pretax adjusted profit margin was 31.3%, against 31.6% a year earlier.
- U.S. pretax margin fell to 17.4%: U.S. pretax adjusted earnings were $300 million, down 9.1%, on higher benefits and expenses, partly offset by higher premiums. The U.S. pretax adjusted profit margin was 17.4%, against 19.7%.
- Japan sales rose 15.7% on Miraito: Japan new annualized premium sales rose 15.7% to ¥19.9 billion, or $129 million, mainly reflecting sales of the Miraito cancer insurance product.
From this 10-K
Aflac sells supplemental health and life insurance in Japan and the United States. Supplemental means it sits on top of whatever primary cover the customer already has, and pays cash directly to the policyholder for the out-of-pocket costs a medical event leaves behind. The parent company was incorporated in Georgia in 1973 and the group is licensed in all 50 states, the District of Columbia, several US territories and Japan.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 17,164 | 18,927 | 18,701 | -9.3% | |
| Selling, general and administrative | 3,253 | 3,014 | 3,165 | +7.9% | |
| Operating income | 4,533 | 6,417 | 5,262 | -29.4% | |
| Operating margin | 26.4% | 33.9% | 28.1% | ||
| Interest expense | 217 | 194 | 195 | +11.9% | |
| Pre-tax income | 4,533 | 6,417 | 5,262 | -29.4% | |
| Income tax | 887 | 974 | 603 | -8.9% | |
| Effective tax rate | 19.6% | 15.2% | 11.5% | ||
| Net income | 3,646 | 5,443 | 4,659 | -33.0% | |
| Net margin | 21.2% | 28.8% | 24.9% | ||
| Diluted EPS | $6.82 | $9.63 | $7.78 | -29.2% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 2,555 | 2,707 | 3,190 | -5.6% | |
| Cash from investing | 1,561 | 2,781 | 817 | -43.9% | |
| Cash from financing | -4,069 | -3,486 | -3,723 | ||
| Depreciation and amortisation | 36.0 | 40.0 | 39.0 | -10.0% | |
| Buybacks | 3,530 | 2,800 | 2,801 | +26.1% | |
| Dividends paid | 1,198 | 1,087 | 966 | +10.2% | |
| Dividend per share | $2.35 | $2.08 | $1.76 | +13.0% | |
| Diluted shares, weighted | 535m | 565m | 599m | -5.3% | |
| Shares outstanding at period end | 519m | 550m | 578m | -5.7% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 29,490 | 26,098 | 21,985 | +13.0% | |
| Debt | 8,330 | 7,402 | 7,240 | +12.5% | |
| Other liabilities | 78,650 | 84,066 | 97,499 | -6.4% | |
| Total liabilities and equity | 116,470 | 117,566 | 126,724 | -0.9% | |
| Fixed assets | 351 | 387 | 445 | -9.3% | |
| Goodwill | 260 | 263 | 265 | -1.1% | |
| Securities held for sale or to maturity | 80,246 | 81,240 | 91,114 | -1.2% | |
| Securities borrowed | 3,945 | 2,001 | 1,480 | +97.2% | |
| Cash and equivalents | 6,245 | 6,229 | 4,306 | +0.3% | |
| Other assets | 25,423 | 27,446 | 29,114 | -7.4% | |
| Total assets | 116,470 | 117,566 | 126,724 | -0.9% |
10-K for the year ended 31 December 2025, filed 25 February 2026: the filing.